Urologic DiseasesNCT05636189
Effect of Prewarming During Induction of General Anesthesia Combined With Warmed Intravenous Fluid on Core Temperature.
A study testing warming during induction of anesthesia and Prewarmed intravenous fluid administration in people with Urologic Diseases, run by Inje University at 1 site in South Korea.
Trial summary
Hypothermia occurs frequently during general anesthesia. This study is to evaluate the efficacy of 10 minutes of prewarming during induction of general anesthesia during urologic surgery. Read more about this study
- Who is it for?
- Ages 20 to 90 yearsHealthy volunteers can take part
- Conditions the study is for
- Urologic Diseases
- What is being tested?
- warming during induction of anesthesia and Prewarmed intravenous fluid administration
- Type of treatment
- Injection or infusion, Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteSouth Korea
- Study dates
- 1 Nov 2022to 8 Aug 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 90 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- patients undergoing urologic surgery(transurethral resection of bladder, prostate)
Who cannot join
- moderate to severe cardiopulmonary, renal impairment
- previous thyroid disease
- any infection sign
- abnormal temperature prior to induction of general anesthesia (<36'C or >37.5'C)
- refusal to participate in the study
- unable to understand the study
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effect of Prewarming During Induction of General Anesthesia Combined With Warmed Intravenous Fluid on Core Temperature in Patients Undergoing Urologic Surgery.
Hypothermia occurs frequently during general anesthesia. This study is to evaluate the efficacy of 10 minutes of prewarming during induction of general anesthesia during urologic surgery.
Read the detailed description
Hypothermia is of continuous issue in patients undergoing general anesthesia. During urologic operation (transurethral resection of bladder and prostate), bladder irrigation worsens hypothermia. Hence, various methods including prewarming of the patient are used to maintain core temperature during operation.
Prewarming is found to be effective in maintaining core temperature perioperatively by increasing peripheral tissue heat content. However, applying more than 30 minutes of prewarming may be impractical as a clinical routine practice. Hence, developing simple and effective method to prevent hypothermia is expected.
Here, the investigators planned to examine the effect of active warming (10 minutes of warming during induction of general anesthesia and prewarmed intravenous fluid intraoperatively) on hypothermia in patients undergoing urologic operation under general anesthesia.
- Conditions
- Urologic Diseases
- Being tested
- warming during induction of anesthesia, Prewarmed intravenous fluid administration
- Medical subject headings
- Urologic Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
warming during induction of anesthesiaProcedure or surgery
Warming group patients are applied air-forced warming device (bair-hugger 43'C) with blanket (warm touch, COVIDIEN, full body blanket) during induction of anesthesia in the operation room.
Prewarmed intravenous fluid administrationProcedure or surgery
Prewarmed intravenous fluid is connected.
| Study group | Role | What they receive |
|---|---|---|
| warming group | Active comparator | warming of the patient with whole body warming blanket in the OR during induction of anesthesia, prewarmed intravenous fluid during the operation. Receives: Procedure: warming during induction of anesthesia; Procedure: Prewarmed intravenous fluid administration |
| no warming group | No intervention | There will be no whole body warming during induction. |
What is being measured
The primary outcome is the main question the study is designed to answer.
incidence of hypothermia at the end of the operation
number of patients with hypothermia (<36'C) using esophageal stethoscope will be recorded.
Measured: approximately 1-2hours after induction (at the end of operation)
Secondary outcomes (3)
change in temperature drop before and end of operation
change in core temperature will be observed
Measured: on arrival at the OR upto 1-2hours after induction (at the end of the operation)
thermal comfort
thermal comfort scale ( 0= very cold, 5= fine, 10= very hot and uncomfortable) will be used.
Measured: upto 1hour after end of the operation (at discharge of postanesthesia care unit)
incidence of shivering
4 point shivering scale (0=none, 1=core and neck shivering, 2= upper extremity 3= whole body) will be used.
Measured: upto 1 hour after end of the operation (on arrival at the postanesthesia care unit)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Dec 2022
- Study start1 Nov 2022
- Primary completion8 Aug 2023
- Study completion8 Aug 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Urologic DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Inje University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, In-Jung Jun, Inje University
- Investigators
- In-Jung Jun, MD, PhD, Principal investigator, assistant professor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05636189
- Sponsor's protocol ID
- 2022-08-011-001
- Status last verified
- Aug 2023
- First submitted
- 23 Nov 2022
- Last updated
- 30 Aug 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Aug 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Prewarming During Induction of General Anesthesia Combined With Warmed Intravenous Fluid on Core Temperature in Patients Undergoing Urologic Surgery.
- ClinicalTrials.gov ID
- NCT05636189
- Acronym / sponsor ID
- 2022-08-011-001
- Conditions
- Urologic Diseases
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Inje UniversityUniversity, hospital or other
- Study start
- 1 Nov 2022 (actual)
- Primary completion
- 8 Aug 2023 (actual)
- Study completion
- 8 Aug 2023 (actual)
- First posted
- 5 Dec 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Hypothermia occurs frequently during general anesthesia. This study is to evaluate the efficacy of 10 minutes of prewarming during induction of general anesthesia during urologic surgery.
Detailed description
Hypothermia is of continuous issue in patients undergoing general anesthesia. During urologic operation (transurethral resection of bladder and prostate), bladder irrigation worsens hypothermia. Hence, various methods including prewarming of the patient are used to maintain core temperature during operation.
Prewarming is found to be effective in maintaining core temperature perioperatively by increasing peripheral tissue heat content. However, applying more than 30 minutes of prewarming may be impractical as a clinical routine practice. Hence, developing simple and effective method to prevent hypothermia is expected.
Here, the investigators planned to examine the effect of active warming (10 minutes of warming during induction of general anesthesia and prewarmed intravenous fluid intraoperatively) on hypothermia in patients undergoing urologic operation under general anesthesia.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| warming group | Active comparator | Procedure: warming during induction of anesthesia, Procedure: Prewarmed intravenous fluid administrationwarming of the patient with whole body warming blanket in the OR during induction of anesthesia, prewarmed intravenous fluid during the operation. |
| no warming group | No intervention | –There will be no whole body warming during induction. |
Who may qualify
- Ages
- 20 to 90 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- patients undergoing urologic surgery(transurethral resection of bladder, prostate)
Key exclusion criteria (6 listed)
- moderate to severe cardiopulmonary, renal impairment
- previous thyroid disease
- any infection sign
- abnormal temperature prior to induction of general anesthesia (<36'C or >37.5'C)
- refusal to participate in the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| warming during induction of anesthesiaWarming group patients are applied air-forced warming device (bair-hugger 43'C) with blanket (warm touch, COVIDIEN, full body blanket) during induction of anesthesia in the operation room. | Procedure or surgery | warming group |
| Prewarmed intravenous fluid administrationPrewarmed intravenous fluid is connected. | Procedure or surgery | warming group |
Primary outcome
incidence of hypothermia at the end of the operation
Time frame: approximately 1-2hours after induction (at the end of operation)
number of patients with hypothermia (<36'C) using esophageal stethoscope will be recorded.
3 secondary outcomes
change in temperature drop before and end of operation
Time frame: on arrival at the OR upto 1-2hours after induction (at the end of the operation)
thermal comfort
Time frame: upto 1hour after end of the operation (at discharge of postanesthesia care unit)
incidence of shivering
Time frame: upto 1 hour after end of the operation (on arrival at the postanesthesia care unit)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Aug 2023.
- Individual participant dataSharing planned: No
Related trials for Urologic Diseases
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingObservational study
Population Pharmacokinetics of Temocillin in Acute Enterobacterial Pyelonephritis in Children
Pyelonephritis
Active, not recruitingPhase 3
A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
Carcinoma, Renal Cell
Recruiting
Safety and Performance of UCon Patch Electrode
Urinary Incontinence, Urinary Incontinence, Urge
Active, not recruitingPhase 2
Safety and Efficacy of Empagliflozin in Hemodialysis
End Stage Renal Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
In-Jung Jun, MD, PhD principal investigator
assistant professor
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing warming during induction of anesthesia and Prewarmed intravenous fluid administration in people with Urologic Diseases, run by Inje University at 1 site in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
incidence of hypothermia at the end of the operation (time frame: approximately 1-2hours after induction (at the end of operation)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Aug 2023.